Testosterone and low libido in women: sorting signal from noise
Quick answer
Hormonal contraceptives, particularly combined oral contraceptives, can suppress libido via increased SHBG and reduced free testosterone, with some women showing persistent SHBG elevation months after discontinuation (Panzer et al., 2006). The creator's two-year recovery timeline, while longer than average, is consistent with documented cases of prolonged androgen suppression post-pill. Women with persistent low libido after stopping hormonal contraception should have free testosterone, total testosterone, SHBG, DHEA-S, and thyroid levels evaluated rather than attributing symptoms solely to psychological factors.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @sophiaarudy actually say?
She's mostly telling her own story, which is fair. The core claim is that seven years of hormonal birth control wiped out her libido, she felt "numb" even when alone, and it took two full years off the pill for her sex drive to return. She's careful to say "that was just me personally" and acknowledges others recover faster. That caveat matters, and she deserves credit for including it. This is a personal testimony video, not a medical lecture, but it still carries weight with a million viewers.
The framing is emotionally honest. She describes feeling disconnected from her own body, unable to reconcile her emotional love for her partner with a complete absence of physical desire. That dissociation is a real, documented phenomenon. The "you're probably not attracted to him anymore" narrative she pushes back against is also, frankly, outdated and harmful advice that gets recycled constantly online.
Does the science back this up?
Yes, more than the medical establishment once admitted. Combined oral contraceptives suppress ovarian androgen production and increase sex hormone-binding globulin (SHBG), which binds free testosterone, the hormone most directly tied to libido in women. This is not fringe theory. It is basic endocrinology, and studies have confirmed the connection for years.
Panzer et al. (2006, Journal of Sexual Medicine) found that women on oral contraceptives had significantly elevated SHBG levels and lower free testosterone compared to non-users, and critically, SHBG remained elevated in some women even after stopping the pill. That persistent elevation is sometimes called "post-pill SHBG syndrome," though that term is not yet an official diagnosis. A 2013 study by Greco et al. in the same journal corroborated that sexual dysfunction is a real side effect for a subset of users. A 2022 review in Sexual Medicine Reviews (Both et al.) confirmed the association between hormonal contraceptives and reduced sexual desire, though effect sizes vary widely between individuals.
Her two-year recovery timeline is on the longer end, but it is not implausible given the SHBG persistence data. Some women normalize within months. Others do not.
What did they get wrong (or right)?
She got the core biology right without ever naming it. The numbness she describes, physical arousal completely decoupled from emotional desire, maps almost exactly onto the hypoactive sexual desire disorder (HSDD) framework, where neurological and hormonal signals stop working together. That is not just a feeling. That is a measurable pattern.
Where the video gets fuzzier is the mental-versus-physical split. She says late in the video that "it was a lot more mental than I thought it was." That is partially true. Psychological factors like relationship stress, body image, and anxiety absolutely modulate libido. But framing the recovery as primarily "internal work" risks underselling the hormonal mechanism that likely started the whole cascade. Women watching this who are still on birth control and struggling should not walk away thinking it is a mindset problem first. For many, it is a hormone problem first.
She does not make any dangerous claims. She does not recommend a protocol, dose, or supplement. She does not trash any medication. That restraint is actually unusual for this genre of content and worth acknowledging.
What should you actually know?
Hormonal contraceptives affect libido through two primary mechanisms: suppressed androgen production and elevated SHBG that mops up free testosterone. Not every woman experiences this. Studies suggest roughly 15 to 30 percent of combined OCP users report decreased sexual desire, though the actual number is hard to pin down given underreporting and varying definitions.
Recovery after stopping hormonal birth control is genuinely variable. Panzer et al. (2006) found some women's SHBG levels had not returned to baseline even after six months off the pill. Two years, while at the longer end, is within documented range. If you have been off hormonal contraception for more than 12 months and libido has not returned, that warrants a conversation with a provider, not more patience. Low testosterone in women is measurable, treatable, and often overlooked by clinicians who default to "it's probably stress."
Testing worth asking about includes free testosterone, total testosterone, SHBG, DHEA-S, and thyroid function. These are standard labs. If a provider dismisses your concern without running them, that is a red flag. Telehealth platforms that specialize in hormonal evaluation can be a reasonable option when in-office providers dismiss symptoms.
- Hormonal birth control suppresses free testosterone in a meaningful subset of users, not in everyone
- SHBG can remain elevated after stopping the pill, prolonging libido issues
- Two-year recovery is on the longer end but scientifically plausible
- The "you don't love him anymore" explanation is not supported by research and causes real harm
- Persistent low libido after stopping hormonal contraception is a clinical issue, not just a personal growth project
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 4 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Testosterone and low libido in women: sorting signal from noise, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
Testosterone and low libido in women: sorting signal from noise should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
Use the health tools and supporting evidence to prepare questions for your clinician.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
Hormonal contraceptives, particularly combined oral contraceptives, can suppress libido via increased SHBG and reduced free testosterone, with some women showing persistent SHBG elevation months after discontinuation (Panzer et al.
FormBlends verdict
Hormonal contraceptives, particularly combined oral contraceptives, can suppress libido via increased SHBG and reduced free testosterone, with some women showing persistent SHBG elevation months after discontinuation (Panzer et al., 2006). The creator's two-year recovery timeline, while longer than average, is consistent with documented cases of prolonged androgen suppression post-pill. Women with persistent low libido after stopping hormonal contraception should have free testosterone, total testosterone, SHBG, DHEA-S, and thyroid levels evaluated rather than attributing symptoms solely to psychological factors.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Hormonal contraceptives, particularly combined oral contraceptives, can suppress libido via increased SHBG and reduced free testosterone, with some women showing persistent SHBG elevation months after discontinuation (Panzer et al., 2006). The creator's two-year recovery timeline, while longer than average, is consistent with documented cases of prolonged androgen suppression post-pill. Women with persistent low libido after stopping hormonal contraception should have free testosterone, total testosterone, SHBG, DHEA-S, and thyroid levels evaluated rather than attributing symptoms solely to psychological factors.
- Panzer et al. (2006) found SHBG remained significantly elevated in some women even six months after stopping oral contraceptives, supporting prolonged libido disruption
- Approximately 15-30% of combined OCP users report decreased sexual desire, though underreporting makes precise estimates difficult (Both et al., 2022, Sexual Medicine Reviews)
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Panzer et al. (2006) found SHBG remained significantly elevated in some women even six months after stopping oral contraceptives, supporting prolonged libido disruption
- Approximately 15-30% of combined OCP users report decreased sexual desire, though underreporting makes precise estimates difficult (Both et al., 2022, Sexual Medicine Reviews)
- Free testosterone is the hormone most directly tied to female libido and is suppressed by both reduced ovarian androgen output and elevated SHBG on hormonal birth control
- Persistent low libido more than 12 months after stopping hormonal contraception warrants lab evaluation, not just lifestyle intervention
- The claim that low libido means relationship dissatisfaction is not supported by clinical research and contradicts the documented mechanism of androgen-mediated arousal deficit
- Key labs to request if experiencing post-pill low libido: free testosterone, total testosterone, SHBG, DHEA-S, and TSH
- Recovery timelines after stopping hormonal birth control are genuinely variable, ranging from a few months to, in documented cases, over a year or more
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Sophia Rudy · TikTok creator
1.0M views on this video
big sis chat🫶🏼 #lowlibido #lowlibidoclub #hormones #birthcontrol #birthcontrolproblems #femalehormones
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Not medical advice. This video was made by Sophia Rudy, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.